Status
Conditions
Treatments
About
TB-reactive immune cells will be tested in a multiparametric flow cytometry to distinguish an immune response for antigens of Mycobacterium spp. in TB disease/latent infection or a reaction after BCG vaccine.
Full description
The goal of this project is the verification of current cytometric panel of detection antibodies in a wider panel of stimulative immunodominant antigens for CD4+ and CD8+ T cells in combination with adjuvants 2 in a in vitro activating test.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria: active TB, contact with TB infection in previous 3 months before the study
Exclusion Criteria:
120 participants in 3 patient groups
Loading...
Central trial contact
Petra Hadlová, MGR; Karolína Doležalová, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal